Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

BUY
$4.96 - $7.08 $2,033 - $2,902
410 Added 0.17%
243,601 $1.22 Million
Q2 2020

Aug 12, 2020

BUY
$4.84 - $8.02 $182,182 - $301,880
37,641 Added 18.31%
243,191 $1.46 Million
Q1 2020

May 06, 2020

BUY
$4.52 - $8.55 $5,875 - $11,115
1,300 Added 0.64%
205,550 $1.17 Million
Q4 2019

Feb 14, 2020

SELL
$6.14 - $9.3 $14,429 - $21,855
-2,350 Reduced 1.14%
204,250 $1.57 Million
Q3 2019

Nov 07, 2019

BUY
$9.05 - $16.02 $28,960 - $51,264
3,200 Added 1.57%
206,600 $1.87 Million
Q2 2019

Aug 12, 2019

BUY
$13.58 - $18.61 $66,487 - $91,114
4,896 Added 2.47%
203,400 $3.25 Million
Q1 2019

May 14, 2019

BUY
$11.31 - $23.7 $2.25 Million - $4.7 Million
198,504 New
198,504 $3.66 Million

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $752M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.